Crossmark

Clinical significance of quantitative categorization of HER2 fluorescent in situ hybridization results in invasive breast cancer patients treated with HER2-targeted agents

Crossref DOI link: https://doi.org/10.1038/s41379-020-00728-z

Published Print: 2021-04

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Alhamar, Mohamed https://orcid.org/0000-0001-9364-593X
Alkamachi, Bassam

Mehrotra, Harshita

Sanchez, Jessica

Ali, Haythem

Schultz, Daniel

Chitale, Dhananjay A. https://orcid.org/0000-0002-4421-6431
License Information

Text and Data Mining valid from 2021-04-01

Version of Record valid from 2023-01-11
More Information

This article is maintained by: Elsevier

Article Title: Clinical significance of quantitative categorization of HER2 fluorescent in situ hybridization results in invasive breast cancer patients treated with HER2-targeted agents

Journal Title: Modern Pathology

CrossRef DOI link to publisher maintained version: https://doi.org/10.1038/s41379-020-00728-z

Content Type: article

Copyright: © 2021 United States & Canadian Academy of Pathology.

Document is current

Any future updates will be listed below